Mostrar el registro sencillo del ítem
| dc.contributor.author | Bellido, Virginia | |
| dc.contributor.author | Cebrián-Cuenca, Ana-María | |
| dc.contributor.author | Morales, Cristobal | |
| dc.contributor.author | de-las-Hazas, Alberto-S | |
| dc.contributor.author | Soto-González, Alfonso | |
| dc.contributor.author | Morer-Linan, Carla | |
| dc.contributor.author | Borrachero-Guijarro, José-Miguel | |
| dc.contributor.author | Cuatrecases, Gabriel | |
| dc.contributor.author | García, Elena-L | |
| dc.contributor.author | López-Fernández, Judith | |
| dc.contributor.author | Lozano-García, Silvia | |
| dc.contributor.author | Bayon, Alvaro-M | |
| dc.contributor.author | Nino-Azcarate, Cristina-M | |
| dc.contributor.author | Laclaustra, Oscar | |
| dc.contributor.author | Fuentealba, Paulina | |
| dc.date.accessioned | 2026-10-28T08:18:24Z | |
| dc.date.available | 2026-10-28T08:18:24Z | |
| dc.date.issued | 2026-09 | |
| dc.identifier.citation | Bellido V, Cebrián A, Morales C, De Las Hazas AS, Soto-Gonzalez A, Morer-Liñan C, et al. Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study. Diabetes Ther. septiembre de 2026;17(9):1385-405. doi:10.1007/s13300-026-01903-2 | |
| dc.identifier.issn | 1869-6953 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/29075 | |
| dc.description.abstract | INTRODUCTION: Hypoglycemia is a common complication in people with type 2 diabetes mellitus (T2DM) treated with basal insulin, yet its true prevalence in real-world primary care remains underexplored. This study used blinded continuous glucose monitoring (CGM) to assess glycemic patterns in patients with T2DM on basal insulin-supported oral therapy (BOT) with insulin glargine 100 U/mL (Gla-100) in Spain. METHODS: GPDetect was a prospective, multicenter, observational study in adults with T2DM treated with Gla-100 for ? 6 months in primary care. Participants underwent 14 days of blinded CGM (FreeStyle Libre(®) Pro iQ(®)). The primary objective of the present study was to estimate the proportion of patients with T2DM treated with Gla-100 whose TBR (glucose < 70 mg/dL) exceeded the internationally recommended threshold of 4%. Secondary endpoints included time in range (TIR), time above range (TAR), episodes of clinically significant hypoglycemia (< 54 mg/dL), cognitive function (MMSE), and fear of hypoglycemia (EsHFS). RESULTS: Among 136 patients (mean age 69 years), 16.9% had TBR > 4%, with a higher prevalence at night (23.5%) than during the day (12.5%). Clinically significant hypoglycemia (< 54 mg/dL > 1%) occurred in 8.8% of patients. Hyperglycemia was common: 46.3% spent > 25% of the day between 181-250 mg/dL, and 28.7% spent time > 250 mg/dL. Only 55.9% achieved TIR ? 70%. Patients receiving SGLT2i had lower mean glucose and EsHFS scores. Cognitive impairment (MMSE < 23) was associated with longer hypoglycemia duration. CONCLUSIONS: Blinded CGM revealed a relevant burden of unrecognized hypoglycemia-particularly nocturnal-as well as daytime hyperglycemia in patients with T2DM treated with Gla-100 in primary care. These results support the clinical value of CGM in informing treatment decisions and improving individualized diabetes management. | |
| dc.language.iso | eng | |
| dc.publisher | SPRINGER HEIDELBERG | |
| dc.rights | Atribución/Reconocimiento-NoComercial 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/deed.es | * |
| dc.title | Glycemic Patterns Assessed by Continuous Glucose Monitoring in People with Type 2 Diabetes Treated with Insulin Glargine 100 U/mL in Primary Care: The GPDetect Study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 42554785 | |
| dc.relation.publisherversion | https://link.springer.com/10.1007/s13300-026-01903-2 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1007/s13300-026-01903-2 | |
| dc.journal.title | Diabetes Therapy | |
| dc.identifier.essn | 1869-6961 |